Scott Kathleen D. insider trades
Scott Kathleen D. has filed 21 Form 4s with the SEC that we hold, for ARS Pharmaceuticals, Inc. (SPRY) (Chief Financial Officer), Dermata Therapeutics, Inc. (DRMA) (Director) and NKGN (Director). Across all of them we count 1 purchase worth $51.5K and 5 sales worth $1.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($13). The largest single trade was a sale of 50,000 shares of ARS Pharmaceuticals, Inc. worth $705.0K, dated 2025-05-20. The first filing on our record is dated 2021-08-17 and the latest 2026-06-16.
ARS Pharmaceuticals, Inc. (SPRY)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-11-29 | P, purchase reported on Form 4 | 8,250 | $51.5K | 2022-12-01 | SEC |
| 2024-08-20 | S, sale reported on Form 4 | 12,500 | $200.0K | 2024-08-21 | SEC |
| 2024-10-16 | S, sale reported on Form 4 | 12,500 | $200.0K | 2024-10-17 | SEC |
| 2025-05-20 | S, sale reported on Form 4 | 50,000 | $705.0K | 2025-05-22 | SEC |
| 2025-08-21 | S, sale reported on Form 4 | 12,500 | $187.5K | 2025-08-22 | SEC |
Dermata Therapeutics, Inc. (DRMA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-06-16 | S, sale reported on Form 4 | 11 | $13 | 2026-06-16 | SEC |
NKGN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1794284) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
